Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Hercules Technology Growth Capital (NY: HTGC )

21.48 +0.30 (+1.39%)
Streaming Delayed Price Updated: 1:07 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hercules Technology Growth Capital

< Previous 1 2 3 4 5 6 7 Next >
You Can Buy All 4 of These Ultra-High Yield Dividend Stocks for Less Than $100
Looking for passive income? These stocks have proven track records of paying consistent dividends. 
Via The Motley Fool
Hercules Capital Reports Third Quarter 2023 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2023
From Hercules Capital, Inc.
Via Business Wire
Don’t Forget BDCs For Stable, High-Yield Income
The Fed’s aggressive interest rate increases have been good for business development companies. 
Via Talk Markets
Topics Economy
Exposures Interest Rates
Where Hercules Capital Stands With Analysts
Via Benzinga
Why You Need To Be Buying BDCs Right Now
Via Talk Markets
Recap: Hercules Capital Q1 Earnings
Via Benzinga
This Ultra-High Dividend Stock Pays You Almost 12% to Own It. It Can Be Yours For Less Than $20
Hercules Capital has a rich history of dividend payments and outperforming the competition. 
Via The Motley Fool
Hercules Capital Announces Date for Release of Third Quarter 2023 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Receives Reaffirmed Baa3 Investment Grade Credit and Corporate Rating from Moody’s Investors Service
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors
From Hercules Capital, Inc.
Via Business Wire
Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.
From Hercules Capital, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 30, 2023
Via Benzinga
The 3 Most Promising Pharma Stocks to Own Now
A pillar to economic growth in a defensive area, these promising pharma stocks are set to rise and give investors one bullish ride. 
Via InvestorPlace
When A Secondary Stock Offering Is Great News
A secondary stock offering comes with a sharp drop in a company’s stock price. Rapid price declines make investors nervous, wondering if the company is facing troubles. 
Via Talk Markets
Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser... 
Via Benzinga
RingCentral, Alteryx, International Flavors & Fragrances And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded higher this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
Hercules Capital, Inc. Prices Upsized Public Offering of Common Stock
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital, Inc. Announces Public Offering of Common Stock
From Hercules Capital, Inc.
Via Business Wire
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
Psychedelics biotech COMPASS Pathways’ (NASDAQ: CMPS) consolidated unaudited financial results for the second quarter 2023, ended June 30 are as follows: 
Via Benzinga
Hercules Capital Reports Second Quarter 2023 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Increases Its Total Cash Distribution to $0.48 per Share for the Second Quarter 2023
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Announces Date for Release of Second Quarter 2023 Financial Results and Conference Call
From Hercules Capital, Inc.
Via Business Wire
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
Mental health psychedelics biotech company COMPASS Pathways (NASDAQ: CMPS) received funding for its COMP360 Phase 3 program in Treatment-Resist 
Via Benzinga
Hercules Capital Stock: This Double-Digit Yielder’s Muscles Are Sagging
Hercules hasn’t cut the regular quarterly dividend since 2010. However, the supplemental dividend has been lowered as recently as March of this year. 
Via Talk Markets
The Tech Rally Shows You Need to Buy Stocks Others Hate
It is hard to believe that 2022 was a bear market for tech stocks, with steep price declines. A look at some numbers for a few stocks investors hated last year. 
Via Talk Markets
Hercules Capital: A Specialized, High-Yield BDC That Benefits From Rising Rates
I have four Business Development Companies on my list of recommended stocks. The Fed’s interest rate hikes have proven to be a huge benefit for BDCs. With this in mind, Hercules Capital will continue... 
Via Talk Markets
Hercules Capital Announces Date of 2023 Annual Meeting of Stockholders
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Reports First Quarter 2023 Financial Results
From Hercules Capital, Inc.
Via Business Wire
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the First Quarter 2023
From Hercules Capital, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.